Some financing/dilution.Nothing really negative.2010 was a busy "news cycle" year as I recall.With their cosmetic and cornea "discoveries" and the stock advisory services (Pat Cox and others)having very compelling write-ups and buy recommendations those were busy times. Back to reality though,these developments and the other areas they are concentrating on just take time to "grow feet" and there have been periods of no news which drags a stock down as well.I can't put my finger on any particular event.The management is great,the products and pipeline are there.Lifeline is growing etc.I think the next 12 months will put them back up where they belong.News is king and they are getting back into an active news cycle as their hard work is starting to pay off now.Beginning with Parkinsons.
Market Data 
Markets 
AI
